Skip to main content

Table 2 Association of IVIG treatment with mortality

From: Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

  Total (n) sHR (95% confidence interval) P value
PS matched analysis 236 3.50 (1.98–6.19)  < 0.001
PS adjusted analysis 556* 2.98 (1.92–4.60)  < 0.001
  1. IVIG, intravenous immunoglobulin; PS, propensity score; sHR, sub-distribution hazard ratio
  2. *Propensity score could not be calculated for 34 patients due to complete separation by baseline characteristics